Silence Therapeutics PLC Holding(s) in Company (9195D)
May 02 2013 - 11:52AM
UK Regulatory
TIDMSLN
RNS Number : 9195D
Silence Therapeutics PLC
02 May 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
1. Identity of the issuer or Silence Therapeutics Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ---------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------
Other (please Placing and X
specify): Share Consolidation
---------------------------------------------------------- ------------------------
3. Full name of person(s) Robert Keith
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------
4. Full name of shareholder(s) Rock (Nominees) Limited
(if different from 3.):(iv)
----------------------------------------------------------- ---------------------------
5. Date of the transaction 30 April 2013
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------
6. Date on which issuer 2 May 2013
notified:
----------------------------------------------------------- ---------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 26%, 25%, 24%, 23%
----------------------------------------------------------- ---------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------------------- ----------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
------------- -------------------------- ---------------- ------------ ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- --------- ----------- ------------ ------------ ------------ --------- ------------ -----------
GB00B9GTXM62 454,089,628 454,089,628 9,581,792 9,581,792 20.38%
-------------------------- ---------------- ------------ ------------ --------- ------------ -----------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------------------ ------------------------------ ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ----------- --------------- -------------- ------------------------------------- -----------------------
Spreadbet n/a n/a n/a 796,877 Nominal Delta
--------------- ----------- --------------- -------------- ------------------------------------- ------------ ---------
1.69%
------------- --------- ----------- ------------ ---------- ---------- --------- ------------ ---------
Total (A+B+C)
-----------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------- --------------------------------------------------------------
10,378,669 22.07%
------------------------------------------------------------- --------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------- -------------
11. Number of voting rights proxy
holder will cease
to hold:
-------------------------------------------------------------- -------------
12. Date on which proxy holder will
cease to hold
voting rights:
-------------------------------------------------------------- -------------
13. Additional information:
------------------------------------------------------------ ---------------
14. Contact name: Robert Keith
------------------------------------------------------------ ---------------
15. Contact telephone number:
------------------------------------------------------------ ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUSVROWAVRAR
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Sep 2023 to Sep 2024